610 related articles for article (PubMed ID: 33690729)
21. Metformin treatment exerts antiinvasive and antimetastatic effects in human endometrial carcinoma cells.
Tan BK; Adya R; Chen J; Lehnert H; Sant Cassia LJ; Randeva HS
J Clin Endocrinol Metab; 2011 Mar; 96(3):808-16. PubMed ID: 21190977
[TBL] [Abstract][Full Text] [Related]
22. Metformin is a potent inhibitor of endometrial cancer cell proliferation--implications for a novel treatment strategy.
Cantrell LA; Zhou C; Mendivil A; Malloy KM; Gehrig PA; Bae-Jump VL
Gynecol Oncol; 2010 Jan; 116(1):92-8. PubMed ID: 19822355
[TBL] [Abstract][Full Text] [Related]
23. Endometrial Cancer as a Metabolic Disease with Dysregulated PI3K Signaling: Shedding Light on Novel Therapeutic Strategies.
Kyo S; Nakayama K
Int J Mol Sci; 2020 Aug; 21(17):. PubMed ID: 32842547
[TBL] [Abstract][Full Text] [Related]
24. Hypoxia and hyperglycaemia determine why some endometrial tumours fail to respond to metformin.
Sivalingam VN; Latif A; Kitson S; McVey R; Finegan KG; Marshall K; Lisanti MP; Sotgia F; Stratford IJ; Crosbie EJ
Br J Cancer; 2020 Jan; 122(1):62-71. PubMed ID: 31819173
[TBL] [Abstract][Full Text] [Related]
25. Metformin-mediated growth inhibition involves suppression of the IGF-I receptor signalling pathway in human pancreatic cancer cells.
Karnevi E; Said K; Andersson R; Rosendahl AH
BMC Cancer; 2013 May; 13():235. PubMed ID: 23663483
[TBL] [Abstract][Full Text] [Related]
26. Metformin inhibits follicle-stimulating hormone (FSH) action in human granulosa cells: relevance to polycystic ovary syndrome.
Rice S; Elia A; Jawad Z; Pellatt L; Mason HD
J Clin Endocrinol Metab; 2013 Sep; 98(9):E1491-500. PubMed ID: 23846817
[TBL] [Abstract][Full Text] [Related]
27. Metformin Promotes Anti-tumor Biomarkers in Human Endometrial Cancer Cells.
Pabona JMP; Burnett AF; Brown DM; Quick CM; Simmen FA; Montales MTE; Liu SJ; Rose T; Alhallak I; Siegel ER; Simmen RC
Reprod Sci; 2020 Jan; 27(1):267-277. PubMed ID: 32046384
[TBL] [Abstract][Full Text] [Related]
28. Effects of Metformin on Cellular Proliferation and Steroid Hormone Receptors in Patient-Derived, Low-Grade Endometrial Cancer Cell Lines.
Collins G; Mesiano S; DiFeo A
Reprod Sci; 2019 May; 26(5):609-618. PubMed ID: 29848180
[TBL] [Abstract][Full Text] [Related]
29. Another surprise from Metformin: novel mechanism of action via K-Ras influences endometrial cancer response to therapy.
Iglesias DA; Yates MS; van der Hoeven D; Rodkey TL; Zhang Q; Co NN; Burzawa J; Chigurupati S; Celestino J; Bowser J; Broaddus R; Hancock JF; Schmandt R; Lu KH
Mol Cancer Ther; 2013 Dec; 12(12):2847-56. PubMed ID: 24077915
[TBL] [Abstract][Full Text] [Related]
30. The insulin-sensitizing mechanism of myo-inositol is associated with AMPK activation and GLUT-4 expression in human endometrial cells exposed to a PCOS environment.
Cabrera-Cruz H; Oróstica L; Plaza-Parrochia F; Torres-Pinto I; Romero C; Vega M
Am J Physiol Endocrinol Metab; 2020 Feb; 318(2):E237-E248. PubMed ID: 31874063
[TBL] [Abstract][Full Text] [Related]
31. Metformin inhibits 17β-estradiol-induced epithelial-to-mesenchymal transition via βKlotho-related ERK1/2 signaling and AMPKα signaling in endometrial adenocarcinoma cells.
Liu Z; Qi S; Zhao X; Li M; Ding S; Lu J; Zhang H
Oncotarget; 2016 Apr; 7(16):21315-31. PubMed ID: 26824324
[TBL] [Abstract][Full Text] [Related]
32. Metformin inhibits proliferation and migration of endometrial cancer cells through regulating PI3K/AKT/MDM2 pathway.
Qiang P; Shao Y; Sun YP; Zhang J; Chen LJ
Eur Rev Med Pharmacol Sci; 2019 Feb; 23(4):1778-1785. PubMed ID: 30840303
[TBL] [Abstract][Full Text] [Related]
33. [Preliminary investigation of the expression and functions of insulin receptor isoforms in endometrial carcinoma].
Zhang G; Li XP; Wang JL; Wei LH
Zhonghua Fu Chan Ke Za Zhi; 2012 Nov; 47(11):839-45. PubMed ID: 23302125
[TBL] [Abstract][Full Text] [Related]
34. Metformin administration is more effective when non-obese patients with polycystic ovary syndrome show both hyperandrogenism and hyperinsulinemia.
Genazzani AD; Lanzoni C; Ricchieri F; Baraldi E; Casarosa E; Jasonni VM
Gynecol Endocrinol; 2007 Mar; 23(3):146-52. PubMed ID: 17454168
[TBL] [Abstract][Full Text] [Related]
35. The metabolic status modulates the effect of metformin on the antimullerian hormone-androgens-insulin interplay in obese women with polycystic ovary syndrome.
Romualdi D; De Cicco S; Tagliaferri V; Proto C; Lanzone A; Guido M
J Clin Endocrinol Metab; 2011 May; 96(5):E821-4. PubMed ID: 21307134
[TBL] [Abstract][Full Text] [Related]
36. Anti-diabetic doses of metformin decrease proliferation markers in tumors of patients with endometrial cancer.
Laskov I; Drudi L; Beauchamp MC; Yasmeen A; Ferenczy A; Pollak M; Gotlieb WH
Gynecol Oncol; 2014 Sep; 134(3):607-14. PubMed ID: 24972190
[TBL] [Abstract][Full Text] [Related]
37. Action of metformin on the insulin-signaling pathway and on glucose transport in human granulosa cells.
Rice S; Pellatt LJ; Bryan SJ; Whitehead SA; Mason HD
J Clin Endocrinol Metab; 2011 Mar; 96(3):E427-35. PubMed ID: 21209036
[TBL] [Abstract][Full Text] [Related]
38. Effects of Metformin on Reproductive, Endocrine, and Metabolic Characteristics of Female Offspring in a Rat Model of Letrozole-Induced Polycystic Ovarian Syndrome With Insulin Resistance.
Xie Y; Xiao L; Li S
Front Endocrinol (Lausanne); 2021; 12():701590. PubMed ID: 34484117
[TBL] [Abstract][Full Text] [Related]
39. New therapeutic approaches for the fertility-sparing treatment of endometrial cancer.
Mitsuhashi A; Shozu M
J Obstet Gynaecol Res; 2020 Feb; 46(2):215-222. PubMed ID: 32017321
[TBL] [Abstract][Full Text] [Related]
40. Metformin Treatment Regulates the Expression of Molecules Involved in Adiponectin and Insulin Signaling Pathways in Endometria from Women with Obesity-Associated Insulin Resistance and PCOS.
Oróstica ML; Astorga I; Plaza-Parrochia F; Poblete C; Carvajal R; García V; Romero C; Vega M
Int J Mol Sci; 2022 Apr; 23(7):. PubMed ID: 35409282
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
